Dr Reddy's Laboratories Long-Term Investments 2010-2024 | RDY
Dr Reddy's Laboratories long-term investments from 2010 to 2024. Long-term investments can be defined as the aggregate value of debt and or equity investments with maturities or benefits lasting more than one year.
- Dr Reddy's Laboratories long-term investments for the quarter ending September 30, 2024 were $0.071B, a 0% increase year-over-year.
- Dr Reddy's Laboratories long-term investments for 2024 were $0.063B, a 3.08% decline from 2023.
- Dr Reddy's Laboratories long-term investments for 2023 were $0.065B, a 38.1% decline from 2022.
- Dr Reddy's Laboratories long-term investments for 2022 were $0.105B, a 7.89% decline from 2021.
Dr Reddy's Laboratories Annual Long-Term Investments
(Millions of US $) |
| 2024 |
$63 |
| 2023 |
$65 |
| 2022 |
$105 |
| 2021 |
$114 |
| 2020 |
$41 |
| 2019 |
$49 |
| 2018 |
$71 |
| 2017 |
$106 |
| 2016 |
$50 |
| 2015 |
$62 |
| 2014 |
$13 |
| 2013 |
$13 |
| 2012 |
$7 |
| 2011 |
$7 |
| 2010 |
$7 |
| 2009 |
$5 |
Dr Reddy's Laboratories Quarterly Long-Term Investments
(Millions of US $) |
| 2024-09-30 |
$71 |
| 2024-06-30 |
$63 |
| 2024-03-31 |
$63 |
| 2023-12-31 |
$100 |
| 2023-09-30 |
$71 |
| 2023-06-30 |
$60 |
| 2023-03-31 |
$65 |
| 2022-12-31 |
$76 |
| 2022-09-30 |
$75 |
| 2022-06-30 |
$66 |
| 2022-03-31 |
$105 |
| 2021-12-31 |
$88 |
| 2021-09-30 |
$101 |
| 2021-06-30 |
$128 |
| 2021-03-31 |
$114 |
| 2020-12-31 |
$118 |
| 2020-09-30 |
$54 |
| 2020-06-30 |
$45 |
| 2020-03-31 |
$41 |
| 2019-12-31 |
$46 |
| 2019-09-30 |
$60 |
| 2019-06-30 |
$57 |
| 2019-03-31 |
$49 |
| 2018-12-31 |
$46 |
| 2018-09-30 |
$52 |
| 2018-06-30 |
$53 |
| 2018-03-31 |
$71 |
| 2017-12-31 |
$78 |
| 2017-09-30 |
$74 |
| 2017-06-30 |
$83 |
| 2017-03-31 |
$106 |
| 2016-12-31 |
$109 |
| 2016-09-30 |
$96 |
| 2016-06-30 |
$50 |
| 2016-03-31 |
$50 |
| 2015-12-31 |
$71 |
| 2015-09-30 |
$55 |
| 2015-06-30 |
$77 |
| 2015-03-31 |
$62 |
| 2014-12-31 |
$16 |
| 2014-09-30 |
$15 |
| 2014-06-30 |
$14 |
| 2014-03-31 |
$13 |
| 2013-12-31 |
$13 |
| 2013-09-30 |
$12 |
| 2013-06-30 |
$11 |
| 2013-03-31 |
$13 |
| 2012-12-31 |
$18 |
| 2012-09-30 |
$12 |
| 2012-06-30 |
$11 |
| 2012-03-31 |
$7 |
| 2011-12-31 |
$7 |
| 2011-09-30 |
$7 |
| 2011-06-30 |
$7 |
| 2011-03-31 |
$7 |
| 2010-12-31 |
$7 |
| 2010-09-30 |
$7 |
| 2010-06-30 |
$7 |
| 2010-03-31 |
$7 |
| 2009-12-31 |
$6 |
| 2009-09-30 |
$6 |
| 2009-06-30 |
$6 |
| 2009-03-31 |
$5 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$11.853B |
$3.350B |
|
Dr. Reddy's Laboratories Ltd. is an integrated global pharmaceutical company engaged in providing affordable and innovative medicines since 1984. The company markets its products in countries like the U.S., the UK, Germany, India, Russia, Venezuela, Romania and South Africa. Dr. Reddy's operates through three segments: Global Generics comprising unbranded prescription drugs along with over-the-counter drugs. It includes the operations of the company's biologics business. Pharmaceutical Services & Active Ingredients (PSAI) comprising active pharmaceutical ingredients (API) and custom pharmaceutical services. Proprietary Products and Others involving the new chemical entities, the differentiated formulations business and a dermatology specialty business. The company has a strategic partnership with Glaxo to market selected products across emerging markets outside India.
|
